CDKN2A and central nervous system cancer: For instance, the integrative analysis of the glioma using survClust revealed a small novel subtype characterized by CDKN2A deletion and IDH1/2 mutation (Fig. 2a), whereas the individual platform analysis mostly agreed with previously known subtypes (Additional file 1: Fig. S4d, S6d).